Category: Adma

ADMA Biologics, Inc. (NASDAQ: ) has seen significant trading activity from its CEO Adam S. Grossman, according to recent filings. Grossman was involved in acquisitions and stock disposals on Aug. 26 and 27, totaling more than $13 million in transactions. On the purchase side, Grossman acquired approximately $2.9 million worth…